Influence of the BsmI polymorphism of the vitamin D receptor gene on rheumatoid arthritis clinical activity

Journal of Rheumatology

Volumn 34, Issue 9, 2007, Pages 1823-1826

  Gómez Vaquero, Carmen ^a   Fiter, Jordi ^a   Enjuanes, Ana ^b   Nogués, Xavier ^b   Díez Pérez, Adolfo ^b   Nolla, Joan M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Clinical activity; Rheumatoid arthritis; Vitamin D receptor gene polymorphism

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ENDONUCLEASE BSMI; GLUCOCORTICOID; HEMOGLOBIN; REGULATOR PROTEIN; RHEUMATOID FACTOR; SERUM ALBUMIN; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DNA EXTRACTION; DNA POLYMORPHISM; DNA RESTRICTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE AMPLIFICATION; GENETIC ANALYSIS; GENOTYPE; HEALTH ASSESSMENT QUESTIONNAIRE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; OUTPATIENT DEPARTMENT; PATHOGENESIS; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PRIORITY JOURNAL; RECEPTOR GENE; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RECEPTORS, CALCITRIOL; SEVERITY OF ILLNESS INDEX;

EID: 35948999593     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Harney S, Wordsworth BP. Genetic epidemiology of rheumatoid arthritis. Tissue Antigens 2002;60:465-73.
2. Navarro-Hernandez RE, Oregon-Romero E, Rangel-Villalobos H, et al. sE-Selectin expression and A561C polymorphism in relation to rheumatoid arthritis clinical activity. J Rheumatol 2006;33:1968-72.
3. Costas J, Perez-Pampin E, Ferreiros-Vidal I, et al. SUMO4 and MAP3K7IP2 single nucleotide polymorphisms and susceptibility to rheumatoid arthritis. J Rheumatol 2006;33:1048-51.
4. Lee KH, Kim HS, El-Sohemy A, Cornelis MC, Uhm WS, Bae SC. Cyclooxygenase-2 genotype and rheumatoid arthritis. J Rheumatol 2006;33:1231-4.
5. Manolagas SC, Werntz DA, Tsoukas CD, Provvedini DM, Vaughan JH. 1,25-dihydroxyvitamin D3 receptors in lymphocytes from patients with rheumatoid arthritis. J Lab Clin Med 1986;108:596-600.
6. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag HG. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2005;50:72-7.
7. Cutolo M, Otsa K, Laas K, et al. Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 2006;24:702-4.
8. Cantorna MT, Mahon BD. D-hormone and the immune system. J Rheumatol 2005;32 Suppl 76:11-20.
9. Gough A, Sambrook P, Devlin J, et al. Effect of vitamin D receptor gene alleles on bone loss in early rheumatoid arthritis. J Rheumatol 1998;25:864-8.
10. Rass P, Pakozdi A, Lakatos P, et al. Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis. Rheumatol Int 2006;26:964-71.
11. Maalej A, Petit-Teixera E, Michou L, Rebai A, Cornelis F, Ayadi H. Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun 2005;6:707-11.
12. Goertz B, Fassbender WJ, Williams JC, et al. Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients. Clin Exp Rheumatol 2003;21:333-9.
13. Garcia-Lozano JR, González-Escribano MF, Valenzuela A, García A, Nuñez-Roldán A. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur J Immunogenet 2001;28:89-93.
14. Lee CK, Hong JS, Cho YS, Yoo B, Kim GS, Moon HB. Lack of relationship between vitamin D receptor polymorphism and bone erosion in rheumatoid arthritis. J Korean Med Sci 2001;16:188-92.
15. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:432-42.
16. Esteve-Vives J, Batlle-Guarda E, Reig A, and the Grupo para la adaptación del HAQ a la población española. Spanish version of the Health Assessment Questionnaire: reliability, validity and transcultural equivalency. J Rheumatol 1993;20:2116-22.
17. Wolfe F, Cathey MA. The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol 1991;18:1298-306.
18. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284-7.
19. Strand V, Scott DL, Emery P, Kalden JR, Smolen JS, Cannon GW, for the Leflunomide Rheumatoid Arthritis Investigators Groups. Physical function and health-related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis. J Rheumatol 2005;32:590-601.
20. Nolla JM, Fiter J, Gómez-Vaquero C, Alegre JJ, Valverde J, Roig Escofet D. Value of clinical factors in selecting postmenopausal women with rheumatoid arthritis for bone densitometry. Ann Rheum Dis 2001;60:799-801.